Non-viral gene therapy offers hope for chronic low back pain sufferers
A novel non-viral gene therapy for discogenic back pain (DBP).
FHS
May 20, 2024
Menu
A novel non-viral gene therapy for discogenic back pain (DBP).
Drug product loss is a necessary compromise to manufacture injectable medications. Traditional filling lines often incur losses exceeding one litre for each manufactured batch due
Welsh, Carson, Anderson & Stowe has wiggled out of the grasp of the Federal Trade Commission, but the private equity firm’s anesthesia company, U.S. Anesthesia
In the United States, health care costs are so out of control that medical crowdfunding has become commonplace. The idea is simple: turn your social
WASHINGTON — Bernie Sanders is figuring out just how far bullying drugmakers can take him. For more than a year, Sanders has used his perch
In April, the U.S. Department of Health and Human Services, the world’s most powerful health care agency — responsible for overseeing the largest industry in
Americans, especially Medicare beneficiaries, are getting more medical care these days. Demand from aging Baby Boomers is keeping people in doctor’s offices, and health care
I was 31 years old when my mother was dying of breast cancer. One day, while sitting with her in the hospital, her oncologist asked
It’s no secret that the Mediterranean diet is good for your health. Already recommended to reduce the risks of bowel cancer, heart disease, and dementia,
Medtronic, the global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), the